Skip to main content

Table 4 Correlation between the Participants Hepatitis B Knowledge and Practice

From: Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians

Knowledge

 

YES n(%)

NO n(%)

ra

P

 

(Q13) Referral for chronic HBV management

  

(Q14) Complications of hepatitis B infection

correct

80 (61.5)

50 (38.5)

0.05

0.520

incorrect

4 (50.0)

4 (50.0)

(Q18) Risk of chronic HBV infection

correct

21 (60.0)

14 (40.0)

−0.01

0.904

incorrect

63 (61.2)

40 (38.8)

Combination of Q14 + Q18

correct

20 (62.5)

12 (37.5)

0.02

0.831

incorrect

64 (60.4)

42 (39.6)

 

(Q11) Monitoring of hepatitis B while pregnant

  

(Q17) Risk of newborn developing chronic infection

Correct

33 (76.7)

10 (23.3)

0.18

0.033

Incorrect

55 (57.9)

40 (42.1)

 

(Q6) Vaccination, HBIG

  

(Q17) Risk of newborn developing chronic infection

Correct

38 (88.4)

5 (11.6)

−0.03

0.700

Incorrect

86 (90.5)

9 (9.5)

 

(Q7) Vaccination, Birth dose

  

(Q17) Risk of newborn developing chronic infection

Correct

37 (86.0)

6 (14.0)

−0.03

0.697

Incorrect

84 (88.4)

11 (11.6)

 

(Q8) Vaccination, completion of series

  

(Q17) Risk of newborn developing chronic infection

Correct

24 (55.8)

19 (44.2)

0.10

0.254

Incorrect

43 (45.3)

52 (54.7)

 

(Q9) Vaccination, post vaccine serology testing

  

(Q17) Risk of newborn developing chronic infection

correct

10 (23.3)

33 (76.7)

0.05

0.563

incorrect

18 (18.9)

77 (81.1)

  1. aCorrelation Coefficient
  2. Boldface indicates statistical significance, defined as p-value ≤ 0.05.